In Brief: Biopharmaceutics
This article was originally published in The Tan Sheet
Executive Summary
Biopharmaceutics: Acquires feminine hygiene product line that includes Koromex, Vaginex, and Feminique from London International U.S. Holdings, the U.S. subsidiary of London International Group. Biopharmaceutics is paying $3.6 mil. for the brands, which generate annual sales of approximately $4 mil. The company announced earlier its letter of intent ("The Tan Sheet" Jan. 22, In Brief)...